Plans for a £210m campus dedicated to health and life science businesses in Birmingham have been approved.
The No.1 Birmingham Health Innovation Campus will see 133,000 square feet of laboratory and office space built at the site in Selly Oak. Developer Bruntwood SciTech expects the first phase of the project to be completed in 2023, with work due to begin on site this summer. A main contractor is yet to be formally appointed.
Bruntwood ScitTech managing director David Hardman said the campus reflected the wider region’s health sector development potential. “The region has all the raw ingredients the sector needs: world-class universities, a number of specialist NHS trusts, quality infrastructure and a growing cluster of SMEs to support the journey from early R&D to manufacture and market adoption of new health products and services,” he said.
Date Time
£1.7m project to explore groundbreaking new treatment for biofilm infections in foot ulcers
A new £1.7m project to explore using plasma jets and antimicrobial dressings to treat debilitating – and potentially deadly – wound infections launches today.
The groundbreaking Plasma-activated Antimicrobial Hydrogel Therapy (PAHT) would provide a new treatment modality for biofilm infections in diabetic foot ulcers (DFUs), a type of wound which make up around 10 per cent of the 2.2m wounds reported annually in the UK.
More than a third of the +4.5m diabetics in the UK have a lifetime risk of foot ulcers, of which 50 per cent become infected. Around 10 per cent of these patients then require lower limb amputation due to tissue and bone infection. The prognosis for these patients is bleak; 44 per cent usually die within five years.
Groundbreaking therapy may provide a new treatment modality for biofilm infections in foot ulcers
A new £1.7m project to explore using plasma jets and antimicrobial dressings to treat debilitating - and potentially deadly - wound infections launches today.
The groundbreaking Plasma-activated Antimicrobial Hydrogel Therapy (PAHT) would provide a new treatment modality for biofilm infections in diabetic foot ulcers (DFUs), a type of wound which make up around 10 per cent of the 2.2m wounds reported annually in the UK.
More than a third of the +4.5m diabetics in the UK have a lifetime risk of foot ulcers, of which 50 per cent become infected. Around 10 per cent of these patients then require lower limb amputation due to tissue and bone infection. The prognosis for these patients is bleak; 44 per cent usually die within five years.
Lancaster University hosting city s first COVID-19 vaccination centre miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.